At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Salary Range:CHF159,600.00 - CHF296,400.00 Job Description Summary#LI-Hybrid Location: Basel, Switzerland or East Hanover, United States (see separate posting) Relocation Support: This role is based in Basel, Switzerland. Novartis is unable to offer relocation support: please only
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
ARTIDIS AG is a clinical-stage health-tech start-up founded in Basel, Switzerland that has developed the first atomic force microscopy device for cancer diagnosis and treatment optimization. The ARTIDIS nanotechnology platform integrates different types of clinical data
Today, Lonza is a global leader in life sciences operating across five continents. While we work in science, there’s no magic formula to how we do it. Our greatest scientific solution is talented people working together,
At Roche you can show up as yourself, embraced for the unique qualities you bring. Our culture encourages personal expression, open dialogue, and genuine connections, where you are valued, accepted and respected for who you are,
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
At Machine Learning Architects Basel (MLAB), we assist and empower people and organizations in designing, building, and operating reliable data and machine learning solutions. In doing so, our data and AI journeys and effective solution patterns
Head of The Lab – OverviewThe Lab is Roche’s enterprise capability that delivers content services and digital engagement across the organization. It combines execution, AI, content, technology, operations and delivery to provide high-quality, scalable customer engagement.ResponsibilitiesDefine the
Summary We’re a team of dedicated and passionate people united by a drive to achieve together. This is a senior leadership role accountable for defining and delivering the AI strategy that transforms how Novartis Corporate Affairs
Job Description If you are passionate about infrastructure, consulting and helping clients make better long term investment decisions, we invite you to take on responsibility with us as: YOUR TASKS: Lead individual project workstreams and independently
Full-time Department: Other Contract Type: Permanent Company Description AFRY is a leading European engineering, design and consulting services company with a global presence. As a company, we are driving the transition to a more sustainable society. We
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Job description Location : Zurich, Basel, Geneva Work Pattern Percentage : 80-100% You bring ambition, we provide opportunities Help our clients navigate the future by aligning AI innovation with strategic business goals to drive sustainable growth
Director in Quality & Regulatory Management - Advisory Services Grow here. Go further. Zürich by agreement 100% Advisory Everyone welcome ID: WD Your Impact Sell, lead and, together with the team, deliver high-impact projects engaging with
At Machine Learning Architects Basel (MLAB), we assist and empower people and organizations in designing, building, and operating reliable data and machine learning solutions. In doing so, our data and AI journeys and effective solution patterns
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)